Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Neurogenetics ; 6(2): 67-72, 2005 May.
Article in English | MEDLINE | ID: mdl-15830246

ABSTRACT

Migraine is a prevalent neurovascular disease with a significant genetic component. Linkage studies have so far identified migraine susceptibility loci on chromosomes 1, 4, 6, 11, 14, 19 and X. We performed a genome-wide scan of 92 Australian pedigrees phenotyped for migraine with and without aura and for a more heritable form of "severe" migraine. Multipoint non-parametric linkage analysis revealed suggestive linkage on chromosome 18p11 for the severe migraine phenotype (LOD*=2.32, P=0.0006) and chromosome 3q (LOD*=2.28, P=0.0006). Excess allele sharing was also observed at multiple different chromosomal regions, some of which overlap with, or are directly adjacent to, previously implicated migraine susceptibility regions. We have provided evidence for two loci involved in severe migraine susceptibility and conclude that dissection of the "migraine" phenotype may be helpful for identifying susceptibility genes that influence the more heritable clinical (symptom) profiles in affected pedigrees. Also, we concluded that the genetic aetiology of the common (International Headache Society) forms of the disease is probably comprised of a number of low to moderate effect susceptibility genes, perhaps acting synergistically, and this effect is not easily detected by traditional single-locus linkage analyses of large samples of affected pedigrees.


Subject(s)
Chromosomes, Human, Pair 18 , Gene Expression Profiling , Genomics , Migraine without Aura/genetics , Genetic Linkage , Genetic Predisposition to Disease , Humans , Pedigree , Phenotype
2.
Pharmacogenomics J ; 4(6): 374-8, 2004.
Article in English | MEDLINE | ID: mdl-15303110

ABSTRACT

A practical limitation to the identification of genetic profiles predictive of drug-induced adverse events is the number of patients with the adverse event that can be tolerated before the drug is withdrawn. Whole genome screening for regions of linkage disequilibrium (LD) associated with a particular phenotype may provide the mechanism to rapidly discover specific and sensitive profiles. We have used data from a large phase III clinical trial of tranilast and typed 76 SNPs over a 2.7 megabase region flanking the uridine diphosphate glucuronosyltranserferase 1A1 gene. Three SNPs within one LD block showed strong association with tranilast-induced hyperbilirubinemia (P<10(-13)). Our data illustrated that a genome-wide LD scan of 100,000-200,000 SNPs is sufficient to identify a pharmacogenetic association with a drug-induced adverse event.


Subject(s)
Linkage Disequilibrium/genetics , Pharmacogenetics/methods , Polymorphism, Single Nucleotide/genetics , Clinical Trials, Phase III as Topic/statistics & numerical data , Glucuronosyltransferase/genetics , Humans , ortho-Aminobenzoates/therapeutic use
3.
Pharmacogenomics J ; 4(1): 49-53, 2004.
Article in English | MEDLINE | ID: mdl-14647407

ABSTRACT

Tranilast (N-(3'4'-demethoxycinnamoyl)-anthranilic acid (N-5)) is an investigational drug for the prevention of restenosis following percutaneous transluminal coronary revascularization. An increase in bilirubin levels was observed in 12% of patients upon administration of tranilast in a phase III clinical trial. To identify the potential genetic factors that may account for the drug-induced hyperbilirubinemia, we examined polymorphisms in the uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) gene in over a thousand patients. Our results suggested that the TA repeat polymorphism in UGT1A1, which predisposes some individuals to Gilbert's syndrome, predicted the susceptibility to tranilast-induced hyperbilirubinemia. The (TA)(7)/(TA)(7) genotype was present in 39% of the 127 hyperbilirubinemic patients vs 7% of the 909 controls (P=2 x 10(-22)). Rapid identification of genetic factors accounting for the observed adverse effect during the course of a double-blind clinical trial demonstrated the potential application of pharmacogenetics in the clinical development of safe and effective medicines.


Subject(s)
Genetic Predisposition to Disease , Gilbert Disease/enzymology , Gilbert Disease/genetics , Glucuronosyltransferase/genetics , Hyperbilirubinemia/genetics , ortho-Aminobenzoates/adverse effects , Dinucleotide Repeats/genetics , Double-Blind Method , Genetic Variation , Humans , Hyperbilirubinemia/chemically induced , Isoenzymes/genetics , Polymorphism, Genetic , Prospective Studies
4.
Proc Natl Acad Sci U S A ; 99(4): 2228-33, 2002 Feb 19.
Article in English | MEDLINE | ID: mdl-11842208

ABSTRACT

Linkage disequilibrium (LD) provides information about positional cloning, linkage, and evolution that cannot be inferred from other evidence, even when a correct sequence and a linkage map based on more than a handful of families become available. We present theory to construct an LD map for which distances are additive and population-specific maps are expected to be approximately proportional. For this purpose, there is only a modest difference in relative efficiency of haplotypes and diplotypes: resolving the latter into 2-locus haplotypes has significant cost or error and increases information by about 50%. LD maps for a cold spot in 19p13.3 and a more typical region in 3q21 are optimized by interval estimates. For a random sample and trustworthy map the value of LD at large distance can be predicted reliably from information over a small distance and does not depend on the evolutionary variance unless the sample size approaches the population size. Values of the association probability that can be distinguished from the value at large distance are determined not by population size but by time since a critical bottleneck. In these examples, omission of markers with significant Hardy-Weinberg disequilibrium does not improve the map, and widely discrepant draft sequences have similar estimates of the genetic parameters. The LD cold spot in 19p13.3 gives an unusually high estimate of time, supporting an argument that this relationship is general. As predicted for a region with ancient haplotypes or uniformly high recombination, there is no clear evidence of LD clustering. On the contrary, the 3q21 region is resolved into alternating blocks of stable and decreasing LD, as expected from crossover clustering. Construction of a genomewide LD map requires data not yet available, which may be complemented but not replaced by a catalog of haplotypes.


Subject(s)
Chromosome Mapping , Genotype , Linkage Disequilibrium , Chromosomes, Human, Pair 19 , Chromosomes, Human, Pair 3 , Evolution, Molecular , Haplotypes , Humans , Models, Genetic , Models, Statistical , Physical Chromosome Mapping/methods , Polymorphism, Single Nucleotide , Time Factors
5.
Genomics ; 78(3): 135-49, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11735220

ABSTRACT

We have identified a migraine locus on chromosome 19p13.3/2 using linkage and association analysis. We isolated 48 single-nucleotide polymorphisms within the locus, of which we genotyped 24 in a Caucasian population comprising 827 unrelated cases and 765 controls. Five single-nucleotide polymorphisms within the insulin receptor gene showed significant association with migraine. This association was independently replicated in a case-control population collected separately. We used experiments with insulin receptor RNA and protein to investigate functionality for the migraine-associated single-nucleotide polymorphisms. We suggest possible functions for the insulin receptor in migraine pathogenesis.


Subject(s)
Alleles , Migraine Disorders/genetics , Polymorphism, Single Nucleotide , Receptor, Insulin/genetics , Base Sequence , Case-Control Studies , Chromosome Mapping , Chromosomes, Artificial, Bacterial , Chromosomes, Human, Pair 19 , DNA Primers , Female , Genetic Predisposition to Disease , Genotype , Humans , Linkage Disequilibrium , Male , Protein Binding , Receptor, Insulin/metabolism , Reproducibility of Results , White People/genetics
8.
Nat Genet ; 22(1): 27-36, 1999 May.
Article in English | MEDLINE | ID: mdl-10319858

ABSTRACT

A whole-genome radiation hybrid (RH) panel was used to construct a high-resolution map of the rat genome based on microsatellite and gene markers. These include 3,019 new microsatellite markers described here for the first time and 1,714 microsatellite markers with known genetic locations, allowing comparison and integration of maps from different sources. A robust RH framework map containing 1,030 positions ordered with odds of at least 1,000:1 has been defined as a tool for mapping these markers, and for future RH mapping in the rat. More than 500 genes which have been mapped in mouse and/or human were localized with respect to the rat RH framework, allowing the construction of detailed rat-mouse and rat-human comparative maps and illustrating the power of the RH approach for comparative mapping.


Subject(s)
Genetic Markers/genetics , Genome , Rats/genetics , Animals , Chromosome Mapping , Chromosomes/genetics , Genes/genetics , Humans , Hybrid Cells , Mice , Molecular Sequence Data
9.
Genome Res ; 7(12): 1153-61, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9414320

ABSTRACT

We have assembled a first-generation anchor map of the mouse genome using a panel of 94 whole-genome-radiation hybrids (WG-RHs) and 271 sequence-tagged sites (STSs). This is the first genome-wide RH anchor map of a model organism. All of the STSs have been previously localized on the genetic map and are located 8.8 Mb apart on average. This mouse WG-RH panel, known as T31, has an average retention frequency of 27.6% and an estimated potential resolution of 145 kb, making it a powerful resource for efficient large-scale expressed sequence tag mapping. [All of the mapping data for the maps presented here have been deposited at the Research Genetics, Inc., web site and can be freely accessed and downloaded at http://www.resgen.com/.]


Subject(s)
Chromosome Mapping , Chromosomes/genetics , Hybrid Cells , Sequence Tagged Sites , Animals , Cell Line , Cricetinae , DNA, Complementary , Fibroblasts , Gene Expression , Genetic Markers , Hybrid Cells/radiation effects , Hybrid Cells/ultrastructure , In Situ Hybridization, Fluorescence , Mice , Polymerase Chain Reaction , Stem Cells , X-Rays
10.
Trends Genet ; 12(12): 491-3, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9257524
11.
Am Rev Respir Dis ; 122(2): 319-23, 1980 Aug.
Article in English | MEDLINE | ID: mdl-7416608

ABSTRACT

We evaluated 2 methods of obtaining lower respiratory tract secretions in 46 patients. One method used an open-end brush-in-catheter system, and the other used a plugged telescoping double-catheter-overbrush device. After passing a bronchofiberscope transnasally into the trachea, one or the other system was advanced under direct vision into the tracheal lumen and the brush advanced without touching the tracheal wall. The brush was removed and its tip cultured. Using the brush-in-catheter system, 83% (19/23) of brush cultures were positive and similar to simultaneously obtained nasopharyngeal cultures. The brush tip from the plugged telescoping double-catheter device was sterile in 100% of the subjects (10/10). Thus, open-end brush-in-catheter systems are not suitable for use in culturing the lower airways because of contamination within the inner channel of the bronchofiberscope from upper airway secretions. The recently introduced plugged telescoping brush system appears suitable for this purpose.


Subject(s)
Bronchi/microbiology , Bronchoscopes , Bronchoscopy/methods , Fiber Optic Technology , Humans , Nasopharynx/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...